Ashley Gallagher

4 days ago | drugtopics.com | Ashley Gallagher

Full results from the SURMOUNT-5 (NCT05822830) phase 3 trial show that tirzepatide (Zepbound) demonstrated superiority compared to semaglutide (Wegovy) across the primary end point and 5 key secondary end points.

4 days ago | drugtopics.com | Ashley Gallagher

Unhealthy eating and inadequate or excessive sleeping duration could contribute to developing diabetic nephropathy, according to results of a study published in the Journal of Diabetes Investigation. However, investigators did not find a significant association between diabetic nephropathy and smoking or drinking.1Diabetic nephropathy is the leading cause of end-stage renal failure in the United States, according to StatPearls.

1 week ago | drugtopics.com | Ashley Gallagher

For older patients with type 2 diabetes (T2D), initiating treatment with angiotensin-converting enzyme inhibitors (ACEIs) was associated with a trend toward lower risk of major adverse cardiac events (MACE) compared with angiotensin II receptor blockers (ARBs), according to results of a study published in Cardiovascular Diabetology.1 Diabetes is a known risk factor for cardiovascular disease, and those with diabetes have a higher risk of developing and dying from diseases such as myocardial...

1 week ago | drugtopics.com | Ashley Gallagher

Johnson & Johnson presented new data for guselkumab (Tremfya) as a treatment for moderately to severely active ulcerative colitis (UC), which is the first and only IL-23 inhibitor that demonstrated robust data as a fully subcutaneous regimen.

1 week ago | drugtopics.com | Ashley Gallagher

Investigators found a decrease in pneumococcal carriage for children with HIV after a pneumococcal conjugate vaccine (PCV). The results of the study published in Clinical and Experimental Vaccine Research showed that vaccination also changed serotype distribution from vaccine-type serotypes to nonvaccine-type serotypes.1Pediatric patients can acquire HIV through perinatal transmission, which is the most common way patients under 13 years get the infection.